knowledge -WSS

knowledge

author：explore 2025-09-03 15:23:33 - browse：3

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Does good food count as health care? Study aims to find out

WSS

PBM reforms clear House panel

Gain of function research would be limited under House proposal

Biogen nominates mother of director’s child to replace him on board

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Biogen nominates mother of director’s child to replace him on board

knowledge

knowledge

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Novo pauses ads for weight loss drug Wegovy amid demand

Virginia high school admissions case could be legal follow

David Sabatini, ex

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Eli Lilly’s Mounjaro succeeds in second weight

Continuity nursing helped my family in our darkest PICU moments

Eli Lilly’s Mounjaro succeeds in second weight

Duchenne breakthrough therapy leaves behind pioneering families

Novo pauses ads for weight loss drug Wegovy amid demand

focus

Biden administration plans revamp of organ transplant system

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Altering the blood type of lungs raises potential for universal organs for transplants

Poor hospice wound care hurts patients and families

Why medical students are struggling with mental health

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

leisure time

focus

focus

hotspot